- 2022.02.01 ypN0 in Patients with Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer
- 2021.12.28 Classifying the destination of right top pulmonary vein in 31 clinical cases
- 2021.12.28 GHSR methylation-dependent expression of a variant ligand and receptor of the ghrelin system induces thymoma tumorigenesis
- 2021.12.28 Hypervascularized bronchial arteries as a risk factor for intraoperative bleeding and prolonged surgery
- 2021.12.28 Diversity of lymphatic flow in patients with lung cancer revealed by computed tomography lymphography
- 2021.12.28 Prognostic Impact of CXCR7 and CXCL12 Expression in Patients with Esophageal Adenocarcinoma
- 2021.12.28 Diagnosis of visceral pleural invasion using confocal laser endomicroscopy during lung cancer surgery
- 2021.12.28 Endobronchial Ultrasound Improves the Diagnosis of the Tracheobronchial Invasion of Advanced Esophageal Cancer
- 2021.12.28 Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients
- 2021.12.28 Long-term outcomes of sentinel node identification using indocyanine green in patients with lung cancer
- 2021.12.28 Evaluation of extended thymectomy approaches based on residual fat tissue
- 2021.06.18 GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors
- 2021.06.18 Cone-beam computed tomography versus computed tomography-guided ultrathin bronchoscopic diagnosis for peripheral pulmonary lesions: A propensity score-matched analysis
- 2021.04.14 Can Computed Tomography Differentiate Adenocarcinoma In Situ from Minimally Invasive Adenocarcinoma?
- 2021.03.29 Biomarkers predicting the response to chemotherapy and the prognosis in patients with esophageal squamous cell carcinoma
- 2020.12.28 Prediction of improvement after extended thymectomy in non-thymomatous myasthenia gravis patients
- 2020.12.28 Evaluation of extended thymectomy approaches based on residual fat tissue
- 2020.12.28 Safe central venous catheters for esophageal cancer treatment
- 2020.12.23 Phase 1 Dose-Escalation Study of Triweekly Nab-Paclitaxel Combined With S-1 for HER2-Negative Metastatic Breast Cancer
- 2020.12.23 Diagnosis of recurrence and follow-up using FDG-PET/CT for postoperative non-small-cell lung cancer patients
